Floatz logo

Haloperidol

Acute Agitation

Qilu Pharmaceutical Co., Ltd.Phase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Acute Agitation cohort.

Asset / SponsorPhaseRating
Olanzapine
Qilu Pharmaceutical Co., Ltd.
Phase 3BB
inp105
Impel Pharmaceuticals
Phase 1CC

Same molecule, other indications

Haloperidol is also rated in:

psychotic disorderDormant
BBB
Indicative ·
76 / 100
View asset →
AgitationDormant
BBB
Indicative ·
73 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →